Publicaciones en colaboración con investigadores/as de Instituto de Neurociencias de Castilla y León (2)

2024

  1. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246

2021

  1. Impairment of autophagic flux participates in the antitumor effects of tat-cx43266-283 in glioblastoma stem cells

    Cancers, Vol. 13, Núm. 17